Although in the past century, the discovery of insulin has improved the therapeutic options for patients with diabetes, certain limiting factors, such as insufficient efficacy, cost, weight gain, and life-threatening hypoglycemic episodes remain the prohibitive challenges that are commonly associated with the use of insulin in humans [2,3]. Here, INS is linked to diabetes mellitus.